 |
|
|
| |
DolPHIN-1: Randomised controlled trial of dolutegravir(DTG)-versus
efavirenz(EFV)-based therapy in mothers initiating antiretroviral
treatment in late pregnancy
|
| |
| |
Reported by Jules Levin
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
C. Orrell, K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S. Walimbwa, E.M. Hodel, A. Hill, S. Khoo, M. Lamorde, on behalf of the DolPHIN-1 Study Group
|
| |
|
|
|
|
|
